ANR — Anatara Lifesciences Share News
0.000.00%
Last trade - 00:00- AU$3.14m
- AU$2.05m
Australia Stock Exchange release from ANATARA LIFESCIE : PRE_NR Ends: 17:16:43
Australia Stock Exchange release from ANATARA LIFESCIE : Appendix 4C & Q1 FY22 Activities Report
Australia Stock Exchange release from ANATARA LIFESCIE : Notification regarding unquoted securities - ANR
Australia Stock Exchange release from ANATARA LIFESCIE : Notification of cessation of securities - ANR
Australia Stock Exchange release from ANATARA LIFESCIE : Appendix 4G and Corporate Governance Statement
Australia Stock Exchange release from ANATARA LIFESCIE : Annual Report to shareholders
Australia Stock Exchange release from ANATARA LIFESCIE : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from ANATARA LIFESCIE : Annual General Meeting & Director Nominations
Australia Stock Exchange release from ANATARA LIFESCIE : Change of Director's Interest Notice
Australia Stock Exchange release from ANATARA LIFESCIE : Notification regarding unquoted securities - ANR
Australia Stock Exchange release from ANATARA LIFESCIE : Meet the CEO Investor Webinar
Australia Stock Exchange release from ANATARA LIFESCIE : PRE_NR Ends: 09:47:59
Australia Stock Exchange release from ANATARA LIFESCIE : Investor Presentation
Australia Stock Exchange release from ANATARA LIFESCIE : Application for quotation of securities - ANR
Australia Stock Exchange release from ANATARA LIFESCIE : Appendix 4E & Financial Report 30 June 2021
Australia Stock Exchange release from ANATARA LIFESCIE : PRE_NR Ends: 10:06:49
Australia Stock Exchange release from ANATARA LIFESCIE : Anatara launches IBS-D Clinical Trial recruitment website
Australia Stock Exchange release from ANATARA LIFESCIE : Notification regarding unquoted securities - ANR
Australia Stock Exchange release from ANATARA LIFESCIE : Application for quotation of securities - ANR